U.S. Markets closed

United States Pneumococcal & Meningococcal Vaccines Market Analysis (2015-2025) with Data on Prevnar/Prevnar 13, Pneumovax 23, Menactra, Bexsero, Menveo, and Trumenba

DUBLIN, Nov. 28, 2019 /PRNewswire/ -- The "United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year-end of 2025.

This report presents an in-depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States pneumococcal & meningococcal vaccines market. The report also explores a detailed analysis of the top 6 vaccines market assessment in the United States from 2015 to 2018 and forecasts to 2025. The report also details the latest information about the pneumococcal & meningococcal vaccines pricing trends and analysis. It also covers reimbursement pattern and offers a clear view of the regulatory landscape.

Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement and partnerships are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccines market.

The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio and recent development.

Key Players
(Business Overview, Vaccines Portfolio, Recent Development)

  • Pfizer
  • Merck
  • Sanofi Pasteur
  • GlaxoSmithKline (GSK)

Top 6 Vaccines Covered

  • Prevnar/Prevnar 13
  • Pneumovax 23
  • Menactra
  • Bexsero
  • Menveo
  • Trumenba

The Latest Industry Data Included

  • The United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 - 2025)
  • The United States Pneumococcal Vaccines Market Size & Analysis (2015 - 2025)
  • United States Meningococcal Vaccines Market Size & Analysis (2015 - 2025)
  • The United States Pneumococcal & Meningococcal Vaccines Market Share & Y-o-Y Growth (%), 2017 - 2025
  • The United States Pneumococcal Vaccines Market Share & Y-o-Y Growth (%), 2015 - 2025
  • The United States Meningococcal Vaccines Market Share & Y-o-Y Growth (%), 2017 - 2025
  • The United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 - 2025
  • The United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
  • The United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
  • The United States Pneumococcal & Meningococcal Vaccines Regulatory System
  • Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
  • Major Deals in the Vaccines Market
  • Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
  • Major Companies Analysis

Key Questions Answered

  • What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 - 2025?
  • What will be the revenue generated by each vaccine during the forecast period?
  • Which vaccine provides the highest market share?
  • How are the overall market and vaccines type growing?
  • What are the key drivers and inhibitors in the current market?
  • What are the various pneumococcal & meningococcal vaccines available in the United States?
  • How is the market predicted to develop in the future?
  • Who are the key players in this market space?

For more information about this report visit https://www.researchandmarkets.com/r/7w57lf

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/united-states-pneumococcal--meningococcal-vaccines-market-analysis-2015-2025-with-data-on-prevnarprevnar-13-pneumovax-23-menactra-bexsero-menveo-and-trumenba-300966593.html

SOURCE Research and Markets